- List
- By Topic
- On Map
- Search Details

Recruiting, Not yet recruiting, Available Studies | Histiocyte
Need help? See RSS Feeds
Choose a feed type:

Recruiting, Not yet recruiting, Available Studies | Histiocyte (5 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT02523040 | Recruiting | A Study of Lenalidomide for Adult Histiocyte Disorders |
|
|
Interventional | Phase 2 |
|
Other / Industry |
|
|
12 | All | 18 Years and older (Adult, Senior) | NCT02523040 | 15-197 | August 2015 | August 2018 | August 2022 | August 14, 2015 | June 2, 2017 |
|
||
2 | NCT03316573 | Recruiting | A Phase 2 Study of Pembrolizumab in Patients With Histiocyte/Dendritic Cell Neoplasms and Biologically Selected Subtypes of Relapsed/Refractory Aggressive Lymphomas |
|
|
Interventional | Phase 2 |
|
Other / Industry |
|
|
30 | All | 18 Years and older (Adult, Senior) | NCT03316573 | 17-448 | December 7, 2017 | May 31, 2021 | May 31, 2025 | October 20, 2017 | March 13, 2018 |
|
||
3 | NCT03233854 | Recruiting | CD19/CD22 Chimeric Antigen Receptor T Cells and Chemotherapy in Treating Patients With Recurrent or Refractory CD19 Positive Diffuse Large B-Cell Lymphoma or B Acute Lymphoblastic Leukemia |
|
|
Interventional | Phase 1 |
|
Other |
|
|
57 | All | 18 Years and older (Adult, Senior) | NCT03233854 | CCT5001 41382 |
September 1, 2017 | September 1, 2025 | September 1, 2035 | July 31, 2017 | January 29, 2018 |
|
||
4 | NCT03038672 | Recruiting | Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas |
|
|
Interventional | Phase 2 |
|
NIH |
|
|
106 | All | 18 Years and older (Adult, Senior) | NCT03038672 | NCI-2017-00120 MC168D 10089 UM1CA186686 |
November 30, 2017 | December 31, 2019 | December 31, 2019 | February 1, 2017 | March 13, 2018 |
|
||
5 | NCT02924402 | Recruiting | Study to Evaluate Safety and Tolerability of XmAb13676 in Patients With CD20-expressing Hematologic Malignancies |
|
|
Interventional | Phase 1 |
|
Industry |
|
|
66 | All | 18 Years and older (Adult, Senior) | NCT02924402 | XmAb13676-01 | October 2016 | August 2020 | September 2020 | October 5, 2016 | December 13, 2017 |
|
† Study has passed its completion date and status has not been verified in more than two years.